Stem definition | Drug id | CAS RN |
---|---|---|
systemic antifungal agents, miconazole derivatives | 2599 | 67915-31-5 |
Dose | Unit | Route |
---|---|---|
80 | mg | V |
None
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 31, 1987 | FDA | JANSSEN PHARMS |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | G01AG02 | GENITO URINARY SYSTEM AND SEX HORMONES GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS Triazole derivatives |
FDA CS | M0002083 | Azoles |
FDA EPC | N0000175487 | Azole Antifungal |
MeSH PA | D000890 | Anti-Infective Agents |
MeSH PA | D000935 | Antifungal Agents |
CHEBI has role | CHEBI:149553 | anticoronaviral drug |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Candidal vulvovaginitis | indication | 72605008 | DOID:2272 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 8.72 | Basic |
pKa2 | 3.04 | Basic |
pKa3 | 1.55 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Sodium/nucleoside cotransporter 1 | Transporter | Ki | 5.37 | DRUG MATRIX | |||||
Alpha-2A adrenergic receptor | GPCR | Ki | 6.43 | DRUG MATRIX | |||||
Sigma non-opioid intracellular receptor 1 | Membrane receptor | Ki | 6.67 | DRUG MATRIX | |||||
Sodium-dependent serotonin transporter | Transporter | Ki | 5.22 | DRUG MATRIX | |||||
Sodium-dependent noradrenaline transporter | Transporter | Ki | 4.60 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2A | GPCR | Ki | 5.63 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2C | GPCR | Ki | 5.44 | DRUG MATRIX | |||||
Alpha-2B adrenergic receptor | GPCR | Ki | 5.90 | DRUG MATRIX | |||||
D(3) dopamine receptor | GPCR | Ki | 5.80 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M1 | GPCR | Ki | 5.86 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M2 | GPCR | Ki | 5.34 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M3 | GPCR | Ki | 5.51 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M4 | GPCR | Ki | 5.72 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M5 | GPCR | Ki | 5.50 | DRUG MATRIX | |||||
Alpha-2C adrenergic receptor | GPCR | Ki | 7.22 | DRUG MATRIX | |||||
Sodium-dependent dopamine transporter | Transporter | Ki | 5.36 | DRUG MATRIX | |||||
Alpha-1D adrenergic receptor | GPCR | Ki | 5.27 | DRUG MATRIX | |||||
Acetylcholinesterase | Enzyme | IC50 | 4.67 | DRUG MATRIX | |||||
Tyrosine-protein kinase Fyn | Kinase | IC50 | 4.96 | DRUG MATRIX | |||||
Lanosterol 14-alpha demethylase | Enzyme | IC50 | 5.52 | CHEMBL | |||||
D(1A) dopamine receptor | GPCR | Ki | 4.90 | DRUG MATRIX | |||||
Lanosterol 14-alpha demethylase | Enzyme | INHIBITOR | WOMBAT-PK | CHEMBL | |||||
5-hydroxytryptamine receptor 4 | GPCR | Ki | 5.61 | DRUG MATRIX | |||||
Heme oxygenase 2 | Enzyme | IC50 | 5.30 | CHEMBL | |||||
Arachidonate 15-lipoxygenase | Enzyme | IC50 | 5.61 | DRUG MATRIX | |||||
Alpha-1B adrenergic receptor | GPCR | Ki | 5.10 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 1B | GPCR | Ki | 4.39 | DRUG MATRIX | |||||
Membrane-associated progesterone receptor component 1 | Membrane receptor | Ki | 6.71 | DRUG MATRIX | |||||
Alpha-1A adrenergic receptor | GPCR | IC50 | 4.88 | CHEMBL | |||||
Heme oxygenase 1 | Enzyme | IC50 | 6.39 | CHEMBL |
ID | Source |
---|---|
4019521 | VUID |
N0000147638 | NUI |
D00888 | KEGG_DRUG |
4019521 | VANDF |
C0076115 | UMLSCUI |
CHEBI:9451 | CHEBI |
CHEMBL1306 | ChEMBL_ID |
DB00251 | DRUGBANK_ID |
C037815 | MESH_SUPPLEMENTAL_RECORD_UI |
4815 | INN_ID |
0KJ2VE664U | UNII |
441383 | PUBCHEM_CID |
37806 | RXNORM |
46326 | MMSL |
5549 | MMSL |
002931 | NDDF |
25860005 | SNOMEDCT_US |
387140007 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0168-0346 | CREAM | 4 mg | VAGINAL | ANDA | 21 sections |
TerconazoleVaginal Cream 0.8% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0168-0347 | CREAM | 8 mg | VAGINAL | NDA | 21 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0713-0552 | SUPPOSITORY | 80 mg | VAGINAL | ANDA | 24 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0713-0552 | SUPPOSITORY | 80 mg | VAGINAL | ANDA | 24 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-844 | CREAM | 4 mg | VAGINAL | ANDA | 22 sections |
TERCONAZOLE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-933 | CREAM | 8 mg | VAGINAL | NDA | 21 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45802-717 | SUPPOSITORY | 80 mg | VAGINAL | ANDA | 20 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 45802-717 | SUPPOSITORY | 80 mg | VAGINAL | ANDA | 20 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0917 | CREAM | 4 mg | VAGINAL | ANDA | 23 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-0917 | CREAM | 4 mg | VAGINAL | ANDA | 23 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-1196 | CREAM | 8 mg | VAGINAL | ANDA | 23 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-1196 | CREAM | 8 mg | VAGINAL | ANDA | 23 sections |
TERCONAZOLE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-1901 | CREAM | 8 mg | VAGINAL | NDA AUTHORIZED GENERIC | 25 sections |
TERCONAZOLE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-2341 | CREAM | 4 mg | VAGINAL | NDA AUTHORIZED GENERIC | 25 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-6266 | CREAM | 4 mg | VAGINAL | ANDA | 21 sections |
TerconazoleVaginal Cream 0.8% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-6299 | CREAM | 8 mg | VAGINAL | NDA | 21 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51672-1302 | CREAM | 8 mg | VAGINAL | ANDA | 24 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51672-1304 | CREAM | 4 mg | VAGINAL | ANDA | 24 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51672-1330 | SUPPOSITORY | 80 mg | VAGINAL | ANDA | 25 sections |
TERCONAZOLE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 52959-811 | CREAM | 4 mg | VAGINAL | NDA | 21 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53002-7240 | CREAM | 8 mg | VAGINAL | ANDA | 23 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53002-7240 | CREAM | 8 mg | VAGINAL | ANDA | 23 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53002-8130 | CREAM | 4 mg | VAGINAL | ANDA | 23 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 53002-8130 | CREAM | 4 mg | VAGINAL | ANDA | 23 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-5183 | CREAM | 8 mg | VAGINAL | ANDA | 12 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-6160 | CREAM | 4 mg | VAGINAL | ANDA | 21 sections |
TERCONAZOLE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 55045-3259 | CREAM | 8 mg | VAGINAL | NDA | 21 sections |
TerconazoleVaginal Cream 0.8% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8837 | CREAM | 8 mg | VAGINAL | NDA | 21 sections |
TerconazoleVaginal Cream 0.8% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8837 | CREAM | 8 mg | VAGINAL | NDA | 21 sections |
Terconazole | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68071-1626 | CREAM | 8 mg | VAGINAL | ANDA | 24 sections |